Literature DB >> 19551611

Cytotoxic activity and cell cycle analysis of quinoline alkaloids isolated from Haplophyllum canaliculatum Boiss.

Pegah Varamini1, Katayoun Javidnia, Mohammad Soltani, Ahmad Reza Mehdipour, Abbas Ghaderi.   

Abstract

Bioassay-guided fractionation of Haplophyllum canaliculatum Boiss. (Rutaceae) extract resulted in isolation of five quinoline alkaloids: 7-isopentenyloxy-gamma-fagarine, atanine, skimmianine, flindersine and perfamine. This is the first isolation of these compounds from this endemic species. The antitumor activity of these five isolates was evaluated against RAJI, Jurkat, KG-1a, HEP-2, MCF-7, HL-60 and HL-60/MX1 tumor cell lines. The highest cytotoxic effect was observed on acute lymphoblastic leukemia cell lines. 7-Isopentenyloxy-gamma-fagarine, atanine, skimmianine and flindersine exhibited very high cytotoxicity against the RAJI cell line with IC(50) values of 1.5, 14.5, 15.6 and 14.9 microg/mL, respectively and 7-isopentenyloxy-gamma-fagarine, atanine and skimmianine exhibited very high cytotoxicity against the Jurkat cell line with IC(50) values of 3.6, 9.3 and 11.5 microg/mL, respectively. 7-Isopentenyloxy-gamma-fagarine was also highly cytotoxic against the MCF-7 cell line (IC(50) = 15.5 microg/mL), while atanine, skimmianine, flindersine and perfamine showed moderate to low activity against these cells. All alkaloids had moderate to low cytotoxicity against KG-1a and HEP-2. Investigation of the toxic potential of the alkaloids on HL-60 and HL-60/MX1 showed a significantly higher effect against HL-60/MX1, a multidrug-resistant cell line, compared with the control etoposide (p < 0.05). In all cytotoxicity experiments, peripheral blood mononuclear cells (PBMC) were used as a control for normal hematopoietic cells. Flow cytometry analysis of the compounds resulted in the arrest of cell cycle progression at the sub-G1 phase of the RAJI and Jurkat cell lines in a dose-dependent manner. According to computational analyses, the similar cytotoxic trend in the cell lines could be indicative of the fact that these compounds may act through parallel mechanisms. Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19551611     DOI: 10.1055/s-0029-1185807

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  6 in total

Review 1.  Biologically active quinoline and quinazoline alkaloids part II.

Authors:  Xiao-Fei Shang; Susan L Morris-Natschke; Guan-Zhou Yang; Ying-Qian Liu; Xiao Guo; Xiao-Shan Xu; Masuo Goto; Jun-Cai Li; Ji-Yu Zhang; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2018-02-27       Impact factor: 12.944

2.  Phytochemical Content and Pharma-Nutrition Study on Eleutherococcus senticosus Fruits Intractum.

Authors:  Daniel Załuski; Marta Olech; Agnieszka Galanty; Robert Verpoorte; Rafał Kuźniewski; Renata Nowak; Anna Bogucka-Kocka
Journal:  Oxid Med Cell Longev       Date:  2016-10-24       Impact factor: 6.543

Review 3.  Medicinal Plants from Near East for Cancer Therapy.

Authors:  Mohammad S Abu-Darwish; Thomas Efferth
Journal:  Front Pharmacol       Date:  2018-01-31       Impact factor: 5.810

4.  Metabolic Profile of Skimmianine in Rats Determined by Ultra-Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Tandem Mass Spectrometry.

Authors:  Aihua Huang; Hui Xu; Ruoting Zhan; Weiwen Chen; Jiawei Liu; Yuguang Chi; Daidi Chen; Xiaoyu Ji; Chaoquan Luo
Journal:  Molecules       Date:  2017-03-23       Impact factor: 4.411

5.  Secondary metabolites from the stem of Ravenia spectabilis Lindl.

Authors:  Md Mozammel Haque; Sufia Begum; Md Hossain Sohrab; Monira Ahsan; Choudhury M Hasan; Nuruddin Ahmed; Rashedul Haque
Journal:  Pharmacogn Mag       Date:  2013-01       Impact factor: 1.085

6.  Determination of antibacterial activity and metabolite profile of Ruta graveolens against Streptococcus mutans and Streptococcus sobrinus.

Authors:  Hamzah Abdulrahman Salman; Sankarasetty Venkatesh; Ramasamy Senthilkumar; B S Gnanesh Kumar; Aamer Mousa Ali
Journal:  J Lab Physicians       Date:  2018 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.